Company Profiles

CEOLIVE Profiles Up and Coming Innovative Companies

$OPXS | Optex Systems Receives Major Order from U.S. Army
2 May
2016
Written by Mike Elliott

$OPXS | Optex Systems Receives Major Order from U.S. Army »

In this episode of the CEOLIVE.TV Investor Profile Series we talk to Mr. Danny Schoening, CEO of Optex Systems Holdings, a leading manufacturer of optical sighting systems and assemblies for domestic and foreign militaries which trades under ticker OPXS.

Read more...
$XXII | 22nd Century Group Patent Portfolio Focused on $700 Billion Market
25 Apr
2016
Written by Mike Elliott

$XXII | 22nd Century Group Patent Portfolio Focused on $700 Billion Market »

In this episode we will be talking to Mr. Gregg Gellman, Director of Business Development and Regulatory Affairs for 22nd Century Group, a plant biotechnology company that is a leader in tobacco harm reduction and trades under ticker XXII.

Read more...
$PULM | Pulmatrix iSPERSE Provides Major Advance in Drug Delivery
18 Apr
2016
Written by Mike Elliott

$PULM | Pulmatrix iSPERSE Provides Major Advance in Drug Delivery »

Pulmatrix uses an approach, originally pioneered at Harvard and the Massachusetts Institute of Technology, that represents a major advancement in delivering drugs to the lungs of patients with pulmonary disease.

Read more...
$PGTK | Emerging Clean Tech Leader Secures JV with POWERCHINA
4 Apr
2016
Written by Mike Elliott

$PGTK | Emerging Clean Tech Leader Secures JV with POWERCHINA »

Pacific Green Technologies Inc. is focussed on addressing the world's need for cleaner and more sustainable energy. The company's strategy is to build through organic development and acquisition, a portfolio of patented competitive cutting edge technologies designed to meet increasingly stringent environmental standards.

Read more...
$SCQBF | Emerging Global Leader in Multi-Billion Dollar Data Encryption Market
3 Apr
2016
Written by Mike Elliott

$SCQBF | Emerging Global Leader in Multi-Billion Dollar Data Encryption Market »

SecureCom is an emerging global leader in the Data Encryption Software space, which according to a recent report from Research and Markets is expected to reach over $2 billion by 2020.

Read more...
$INNV | An Undervalued Pharma Company with Strong Commercial Pipeline and Solid Revenues
21 Mar
2016
Written by Mike Elliott

$INNV | An Undervalued Pharma Company with Strong Commercial Pipeline and Solid Revenues »

In this episode of the CEOLIVE.TV Investor Profile Series we interview Dr. Bassam Damaj, CEO of Innovus Pharmaceuticals. Dr. Damaj discusses recent acquisitions, the company's strong commercial pipeline and why Innovus Pharmaceuticals (INNV) is undervalued right now.

Read more...

Login

Lost your password?